Last week saw a large number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here’s why brokers think investors ought to buy them next week:
Bank of Queensland Limited (ASX: BOQ)
According to a note out of Morgans, its analysts have upgraded this regional bank’s shares to an add rating with a $7.20 price target. The broker made the move after Bank of Queensland delivered a full year result ahead of its expectations. This was driven by strong net interest income. Looking ahead, the broker notes that its forecasts are ahead of the consensus estimates. However, it feels these estimates are more than achievable. While I see more value in some of the big four banks, Bank of Queensland does look like a decent option.
Medibank Private Ltd (ASX: MPL)
A note out of Morgan Stanley reveals that its analysts have upgraded this private health insurer’s shares to an overweight rating with an improved price target of $3.10. The broker made the move after lifting its earnings forecasts to account for lower than previously expected claims. In addition to this, the broker believes that Medibank is well-placed to achieve its policyholder growth targets in FY 2021. While I think the broker makes some good points, I still have concerns over affordability issues. Until they are resolved, I’m staying clear of the industry.
Telstra Corporation Ltd (ASX: TLS)
Analysts at UBS have retained their buy rating and $3.70 price target on this telco giant’s shares. According to the note, the broker has lifted its dividend estimates in response to comments at its annual general meeting last week. It notes that the Telstra board has revealed that it is willing to adjust its dividend policy to maintain its 16 cents per share fully franked dividend. This will be done if it believes this dividend can be sustained beyond the NBN rollout. UBS appears confident this is possible. I agree with the broker and feel Telstra would be a great option for income investors.
Forget what just happened. We think this stock could be Australia's next MONSTER IPO...
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting...
Because 'Doc' Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget 'buy now pay later', this stock could be the next hot stock on the ASX.
Returns as of 6th October 2020
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- 4 outstanding ASX 200 shares to buy with $4,000 – October 31, 2020 4:30pm
- 2 top ASX tech shares to buy after the recent market turmoil – October 31, 2020 2:30pm
- Is the Adore Beauty (ASX:ABY) share price in the buy zone? – October 31, 2020 12:00pm